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Familial cylindromatosis (turban tumor syndrome;
Brooke±Spiegler syndrome) (OMIM numbers
123850, 132700, 313100, and 605041) is a rare autoso-
mal dominantly inherited tumor syndrome. The dis-
order can present with cutaneous adnexal tumors
such as cylindromas, trichoepitheliomas, and spira-
denomas, and tumors preferably develop in hairy
areas of the body such as head and neck. In affected
families, mutations have been demonstrated in the
CYLD gene located on chromosome 16q12±13 and
reveal the characteristic attributes of a tumor sup-
pressor. Here, we studied familial cylindromatosis in
a multigeneration family of German origin.
Clinically, some individuals only revealed discrete
small skin-colored tumors localized in the nasolabial
region whereas one family member showed expan-
sion of multiple big tumors on the trunk and in a
turban-like fashion on the scalp. Histologically,
cylindromas as well as epithelioma adenoides cysti-
cum were found. We detected a frameshift mutation
in the CYLD gene, designated 2253delG, underlying
the disorder and were able to show that a single
mutation can result in distinct clinical and histologic
expression in familial cylindromatosis. The reasons
for different expression patterns of the same genetic
defect in this disease remain elusive, however.
Identi®cation of mutations in the CYLD gene enable
us to rapidly con®rm putative diagnoses on the gen-
etic level and to provide affected families with gen-
etic counseling. Key words: adnexal and skin appendage
neoplasms/apocrine glands/DNA mutational analysis/
eccrine glands. J Invest Dermatol 119:527±531, 2002
I
n 1892 and 1899, respectively, Brooke and Spiegler for the
®rst time described the familial occurrence of multiple
tumors of skin appendages, a disease nowadays referred to as
familial cylindromatosis, turban tumor syndrome, or
Brooke±Spiegler syndrome (OMIM numbers 123850,
132700, 313100, and 605041) (Brooke, 1892; Spiegler, 1899).
This uncommon tumor syndrome is observed twice as often in
females as in male individuals (Knoth, 1978). Usually in the ®rst or
second decade of life, dermal papules and nodules arise that are
mainly localized in hairy areas of the body with approximately 90%
on the head and neck, rarely on the face or trunk. The tumors are
pink to red in color and their consistency ranges from smooth to
®rm, thus sometimes mimicking neuro®bromas or hypertrophic
scars. They can increase in number as well as size and result in
marked dis®guration. Malignant transformation, primarily to basal
cell epitheliomas, has been described but seems to be rare
(Gerretsen et al, 1993, 1995; Sybert, 1997).
Cylindromas show a typical histopathology. In the dermis,
mosaic-like masses of epithelial cells are surrounded and separated
from each other by thin layers of periodic acid±Schiff (PAS)
positive stroma. Two cell types can be distinguished by electron
microscopy: on the one hand large cells with a moderate amount of
cytoplasm and a vesicular nucleus, and on the other hand small cells
with little cytoplasm and a compact nucleus (Reynes et al, 1976;
Weber et al, 1984).
To date, the cell-type-speci®c origin of familial cylindromas is a
topic of ongoing debate. Whereas some investigators believe in an
eccrine origin, others were able to show apocrine derivatives or
argue for pilar precursors (Reynes et al, 1976; Michal et al, 1999).
Familial cylindromatosis is inherited in an autosomal dominant
fashion with apparently complete penetrance but variable expres-
sion. Recently, linkage of familial cylindromatosis with a locus on
chromosome 16q12±13 was demonstrated (Biggs et al, 1995;
Takahashi et al, 2000) and several groups were able to show loss of
heterozygosity at 16q in sporadic cylindromas as well as familial
cylindromatosis (Biggs et al, 1995; Thomson et al, 1999; Leonard et
al, 2001). In 2000, Bignell and colleagues reported the ®rst
mutations in the CYLD gene causing familial cylindromatosis
(Bignell et al, 2000). The gene consists of 20 exons and obviously
functions as a tumor suppressor (Bignell et al, 2000).
There is increasing evidence that familial cylindromatosis is a
clinically, genetically, and histologically heterogeneous disorder as
the simultaneous occurrence of cylindromas and other tumors of
skin appendages such as trichoepitheliomas and spiradenomas
within affected individuals and families is well documented
(Reynes et al, 1976; Schirren et al, 1995; Puig et al, 1998; Michal
et al, 1999). To date, however, it has not been demonstrated on the
molecular level that these different tumors can indeed arise from
the same mutation in one single gene.
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Here, we studied a four-generation family of German origin by
polymerase chain reaction (PCR), reverse transcriptase (RT)-PCR,
heteroduplex analysis, automated sequencing, and haplotype
analysis. Histologic examination of various tumors from affected
family members revealed cylindromas as well as multiple
trichoepitheliomas, so-called epithelioma adenoides cysticum.
Interestingly, however, mutation analysis performed on leukocyte
DNA as well as tumor DNA and RNA revealed only one
molecular defect in the CYLD gene, designated 2253delG. These
molecular genetic studies for the ®rst time con®rm the previous
clinical notion that one single mutation in a recently identi®ed
tumor suppressor gene underlies phenotypically and histologically
distinct tumors of skin appendages.
MATERIALS AND METHODS
Family and control individuals We studied seven individuals from a
four-generation family of German origin (Fig 1) and 100 unrelated,
unaffected control individuals. In four family members, the diagnosis of
familial cylindromatosis was made by typical clinical and histopathologic
®ndings.
Clinical material and DNA/RNA extraction Ethylenediamine
tetraacetic acid (EDTA) anticoagulated blood samples were drawn from
family members and controls, after informed consent for inclusion in the
study, in accordance with guidelines set forth by the local institutional
review board. Blood samples could not be obtained from individuals I-1
and II-1 (Fig 1) because they were already deceased. From individual I-
1 (Fig 2), however, paraf®n-embedded tumor tissue was available. Thus,
we isolated DNA from skin specimens originally obtained for histologic
examination after excision biopsy.
Further, DNA and RNA was isolated from tumor material of
individuals III-2 and IV-1 (Figs 3, 4) directly after excision.
In total, we isolated and sequenced DNA samples obtained from two
paraf®n-embedded skin specimens of individual I-1, one located on the
nasolabial region and the other on the scalp. Both skin specimens
revealed the histologic characteristics of cylindromas. From individual
III-2 we obtained three skin samples, all of them taken from the
Figure 1. Pedigree of the nuclear family and associated
haplotypes. Affected individuals are indicated by ®lled circles and
squares.
Figure 2. Turban-tumor-like appearance of cylindromas in
individual I-1.
Figure 3. Small cylindromas on the face of individual III-2.
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nasolabial region and demonstrating cylindromas upon histologic examin-
ation. From one of these specimens we isolated DNA and RNA, which
was subjected to automated sequencing analysis. A total of three skin
biopsies were taken from individual IV-1, one of them from the
nasolabial region, one from the back of the nose, and one from the
scalp. The specimen obtained from the nasolabial region showed the
histologic attributes of cylindroma; the two other samples revealed
epithelioma adenoides cysticum. DNA and RNA was isolated from all
three skin samples and subjected to sequencing analysis.
Isolation of genomic DNA from blood specimens was performed
according to standard techniques (Sambrook et al, 1989). For extraction
of DNA and RNA from freshly obtained skin biopsies (individuals III-2
and IV-1; Fig 1) we used PUREGENE DNA puri®cation kits and
PURESCRIPT total RNA puri®cation kits from Gentra (Gentra
Systems, Minneapolis, MN) following the manufacturer's instructions.
For DNA extraction from paraf®n-embedded skin specimens these
samples were ®rst de-paraf®nized. Subsequently, DNA and RNA were
isolated as aforementioned.
PCR, RT-PCR, and mutation detection PCR was performed on
the basis of DNA extracted from EDTA blood where available
(individuals III-1, III-2, III-3, IV-1, and IV-2) or from tumor specimens
(individual I-1). Ampli®cation of all coding exons of the CYLD gene
and the adjacent splice sites was carried out using PCR primers that
were either reported previously (Bignell et al, 2000) or speci®cally
designed by us for this study because the originally published primer
pairs did not yield satisfactory ampli®cation results in our hands. In
detail, we designed new primer pairs for exons 4 and 14 of the CYLD
gene. Primer sequences were CYLD 4bF 5¢-GTCACTTCACCCT-
ACTGG-3¢, CYLD 4bR 5¢-AGCAATTCAACTCCAAAG-3¢, CYLD
14F 5¢-TCCAGCCTGAGTGATAGAGT-3¢, and CYLD 14R 5¢-ACA-
AAAAGAGGAGCTAACCA-3¢. PCR was carried out according to the
following program: initial denaturation at 95°C for 5 min, followed by
35 cycles of denaturation at 95°C for 45 s, annealing at primer-speci®c
temperatures for 1 min (Bignell et al, 2000), and extension at 72°C for 1
min and 15 s; followed by a ®nal extension at 72°C for 10 min, in a
Biometra TGradient thermal cycler (Whatman Biometra, GoÈttingen,
Germany). Each ampli®cation reaction contained »100 ng of genomic
DNA, 50 ng per ml of each forward and reverse primer, and 45 ml of
Platinum Taq PCR Super Mix (Invitrogen Life Technologies, Karlsruhe,
Germany), in a total volume of 50 ml.
For mutation detection, PCR products were subjected to conform-
ation sensitive gel electrophoresis (CSGE) analysis as described previously
(Ganguly et al, 1993). PCR products displaying a heteroduplex on CSGE
analysis were puri®ed in a ®rst step, using the High Pure PCR product
puri®cation kit (Roche, Basel, Switzerland). In a second step, PCR
fragments were puri®ed on Edge Centri¯ex columns (Edge BioSystems,
Gaithersburg, MD) and sequenced directly with POP-6 polymer using
an ABI Prism 310 Genetic Analyzer from Applied Biosystems (Foster
City, CA).
To verify the frameshift mutation in exon 17 identi®ed in this study, a
combination of heteroduplex analysis and automated sequencing was
performed. We studied 200 chromosomes for the presence of this
mutation (data not shown) and thereby excluded it as a common
polymorphism.
To further study tumor tissue on the RNA level, total RNA extracted
from skin specimens was reverse transcribed into cDNA using
ThermoScript RNase H-Reverse Transcriptase (Invitrogen Life
Technologies, Karlsruhe, Germany) according to the manufacturer's
instructions. Ampli®cation of a cDNA fragment containing exons 16±18
of the CYLD gene was performed following the aforementioned PCR
protocol using 10 ml of cDNA, and primers RT-CYLD 16F 5¢-GT-
TTCATCATATTTTAAGGG-3¢ and RT-CYLD 18R 5¢-TATTTAT-
GATTCAGCCTCTT-3¢. RT-PCR products were subcloned using the
TOPO TA cloning kit (Invitrogen Life Technologies, Karlsruhe,
Germany) according to the manufacturer's instructions. Direct sequen-
cing of the cloned fragments into the forward direction was performed
using the M13 forward primer provided with the kit.
Haplotype analysis To identify a common haplotype segregating with
the disease, thereby possibly ruling out unaffected family members,
microsatellite typing was performed. The microsatellite markers used
were D16S517, D16S411, and D16S416, ¯anking the CYLD gene on
Figure 4. Cylindromas and epithelioma adenoides cysticum on
the face of individual IV-1.
Figure 6. Histology of a trichoepithelioma excised from the scalp
of individual IV-1. Hematoxylin and eosin staining. Scale bar: 100 mm.
Figure 5. Histology of a cylindroma excised from the nasolabial
region of individual I-1. PAS staining. Scale bar: 50 mm.
VOL. 119, NO. 2 AUGUST 2002 PHENOTYPE DIVERSITY IN FAMILIAL CYLINDROMATOSIS 529
chromosome 16q12 in telomeric and centromeric directions (Bignell et
al, 2000; http://www.marshmed.org/genetics) (Fig 1). Detailed data and
PCR conditions can be obtained from the Genome Database. Following
electrophoresis on a denaturing sequencing gel, the alleles were
visualized by silver staining as described previously (Budowle et al, 1991).
RESULTS
Histology Skin specimens obtained from the nasolabial region
and scalp of individual I-1 (Fig 2) revealed the typical histologic
features of cylindromas with numerous isolated islands of epithelial
cells that differed in form and size and were surrounded and
separated from each other by hyaline material that showed a PAS
positive staining (Fig 5).
The same histopathologic results were found upon microscopic
examination of tumor material from her granddaughter (Fig 3). In
contrast, however, skin biopsies taken from the nasolabial region,
the dorsum of the nose, and the scalp of her great-grandson (Fig 4)
not only showed cylindromas but also revealed the typical
histologic characteristics of epithelioma adenoides cysticum.
Here, well-demarcated nodules could be seen consisting of small
basaloid cells that were arranged in a palisade-like manner at the
margins (Fig 6).
Haplotype analysis The pedigree of the nuclear family and the
haplotypes obtained with the aforementioned microsatellite
markers are depicted in Fig 1. The results indicate that these
markers were not informative and suf®cient to point out a common
haplotype distinguishing unaffected and affected individuals in this
family, and in the case of individual III-3 they were even
misleading. Individual IV-2 could already be excluded as a
mutation carrier, however.
Mutation analysis Heteroduplex analysis of the PCR fragment
containing exon 17 of the CYLD gene revealed a complex
heteroduplex formation in individuals I-1, III-2, and IV-1 (Fig 7,
top panel). This heteroduplex formation was found in DNA
obtained from blood samples and from all tumor specimens, and
was not observed in 100 control individuals, indicative of a
mutation (data not shown).
Direct sequencing of newly synthesized PCR fragments con-
taining exon 17 showed a frameshift mutation in individuals I-1,
III-2, and IV-1 consisting of a one basepair deletion at nucleotide
position 2253 of the CYLD cDNA, designated 2253delG (Fig 7,
bottom panel). Direct sequencing was likewise performed on DNA
obtained from blood samples and from all tumor specimens and was
also used to prove the absence of this mutation in 100 unrelated
control individuals (data not shown).
Interestingly, direct sequencing of subcloned RT-PCR products
encompassing exons 16±18 of the CYLD gene did not reveal any
sequence deviation in affected individuals. Thus, the mutation was
not detectable on the RNA level by cDNA sequencing.
DISCUSSION
In this study, we identi®ed a frameshift mutation in the CYLD
gene underlying multiple tumors of skin appendages in a German
four-generation family. For the ®rst time we were able to
demonstrate on the molecular level that a hitherto not described
mutation in CYLD can result in phenotypically and histologically
distinct tumors, thereby con®rming earlier clinical and histologic
observations.
Cylindromas have been reported to occur either in a familiar or
in a sporadic fashion. In a recent report, mutations in CYLD, a
gene with the characteristic features of a tumor suppressor, were
shown to cause familial cylindromatosis. In all studied families,
disease penetrance was apparently complete. It was further
demonstrated that CYLD mutations could be found even in
sporadic cylindromas (Bignell et al, 2000). Thus, these sporadic
forms most probably arise due to de novo mutations, either in the
germ line or somatically.
In previous clinical reports, the simultaneous occurrence of
cylindromas and other tumors of skin appendages such as
trichoepitheliomas and spiradenomas has been described in familial
cylindromatosis (Weyers et al, 1993; Schirren et al, 1995; Puig et al,
1998). To date, the nonsyndromatic Mendelian transmission of
isolated spiradenomas has not been reported to our knowledge.
There are several reports, however, that indicate that a familial type
of trichoepithelioma (OMIM 601606) exists in which trichoe-
pitheliomas occur exclusively without other accompanying adnexal
skin tumors. This disease was previously linked to chromosome
9p21. It is not allelic to familial cylindromatosis and therefore has to
be distinguished as a unique entity (Harada et al, 1996).
Interestingly, a variable clinical and histologic expression was also
observed in our study with different members of the same family
presenting with cylindromas either exclusively or in combination
with epithelioma adenoides cysticum. Subsequently, we were able
to demonstrate on the molecular level by mutation analysis
performed on leukocyte DNA as well as tumor DNA and RNA
that the identical mutation in one single gene can give rise to the
Figure 7. Results of heteroduplex and
sequencing analysis. Complex heteroduplex
formation in individuals I-1, III-2, and IV-1 (top
panel). Automated sequence analysis of the
forward strand of the PCR fragment containing
exon 17; deletion of a G-nucleotide in affected
individuals (lower panel, indicated by an arrow)
compared with the wild-type sequence of a
control (middle panel).
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development of clinically and histologically distinct tumors in a
family suffering from familial cylindromatosis.
The frameshift mutation identi®ed in this study consists of a one
basepair deletion at position 2253 of the CYLD cDNA, designated
2253delG (Fig 5, bottom lane), that has not been described
previously. It leads to a premature termination codon 28
nucleotides downstream of the deletion site. As we were not able
to detect the mutated allele upon RT-PCR studies performed on
RNA extracted from cylindromas as well as trichoepitheliomas of
our patients, this premature termination codon will most probably
perturb CYLD protein function through nonsense mediated
messenger RNA decay and might act by haplo-insuf®ciency
(Hentze and Kulozik, 1999). It is also possible, however, that the
mutation might exert a dominant negative effect as CYLD is
believed to be a cytoskeletal protein.
Mutational changes in the CYLD gene could affect the normal
regulation of apocrine or eccrine stem cell populations, which then
give rise to the growth of distinct tumor types because the
physiologic function of the encoded protein is disabled. Thus,
CYLD may play a crucial role in governing cell fate decisions. This
hypothesis by itself, however, cannot explain the variable clinical
expression observed here in three affected family members carrying
the mutation 2253delG. It is therefore possible that either
modifying genes or other hitherto unknown environmental factors
might have an important in¯uence on the distinct differentiation
patterns of tumor cells encountered in familial cylindromatosis.
This notion is also supported by the previous report of Bignell and
colleagues (Bignell et al, 2000).
In affected families, the identi®cation of mutations in the CYLD
gene has greatly enhanced our understanding of familial cylin-
dromatosis. Once a mutation has been identi®ed in a patient
suffering from this disorder, the detection of questionable mutation
carriers with a less severe clinical phenotype is easily accomplished
using molecular biologic techniques. Polymorphic microsatellite
markers ¯anking the CYLD locus on chromosome 16q12±13 and
the locus for familial trichoepitheliomas on chromosome 9p21 will
facilitate clear assignment in those patients with dif®cult clinical
differential diagnosis and presenting a histologic diagnosis of
trichoepithelioma and/or epithelioma adenoides cysticum.
The earlier a diagnosis on the basis of genetic analyses is made,
the higher the chance of providing affected individuals with regular
examinations and small surgical interventions before the full picture
of devastating turban-tumor-like growth can develop, which not
only disables those patients physically but can also lead to
psychologic stress. In our study, genetic analysis allowed exclusion
of the tumor predisposition in a 6-y-old boy (individual IV-2 in
Fig 1) and in another family member (individual III-3 in Fig 1)
who, being afraid of suffering from the disease, had already
undergone surgical excision of some skin lesions on her head and
neck in the past.
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